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CASE REPORTSBioprosthetic valve replacement in idiopathic hypereosinophilic
syndrome with mitral valve involvementQin Fang, MD, Tian-Xiang Gu, MD, Zong-Yi Xiu, MD, and Zhi-Wei Zhang, MD, Shenyang City, ChinaIdiopathic hypereosinophilic syndrome (IHES) is a leuko-
proliferative disorder characterized by cytokine-induced
overproduction of eosinophils, with resultant multiorgan
infiltration and damage. The diagnostic criteria include
evidence of end organ damage, exclusion of all other causes
of eosinophilia, and sustained absolute eosinophil count
greater than 1.5 3 109 cells/L for at least 6 months.1FIGURE 1. A and B, Second admission. A, Renal biopsy sample shows conva
philic infiltration. Masson, Masson trichrome stain; PAS, periodic acid–Schiff s
B, Bone marrow aspiration shows granulocyte series active proliferation with
aspiration biopsy sample shows granulocyte series active proliferation. D, Bone m
than 17% among other cells seen.
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The Journal of Thoracic and CaIHES with cardiac involvement often causes morbidity
and mortality. It is characterized by endocardial fibrosis
and overlying thrombus, leading to restrictive cardiomyop-
athy and valvular dysfunction. The atrioventricular valves
are frequently involved, causing valvular regurgitation.2CLINICAL SUMMARY
A 36-year-old man with a diagnosis of IHES reported
weakness, fever, palpitations, and dyspnea. In the months
before his final admission, the patient was admitted to the
hospital 5 times, with similar symptoms.
In a first admission, his peripheral blood smears showed a
markedly elevated eosinophil count (>8. 50 3 109 cells/L,
60.6% in the differential leukocyte count). Transthoracic
echocardiography (TTE) showed posterior leaflet mitral valve
heteroplasia and moderate mitral regurgitation. In a secondlescence of endocapillary proliferative glomerulonephritis, but no eosino-
tain; PASM, periodic Schiff–methenamine stain; IgM, immunoglobulin M.
an elevated eosinophil ratio. C and D, Third admission. C, Bone marrow
arrow aspiration biopsy reveals the percentage of eosinophils to be greater
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FIGURE 2. A, Transthoracic echocardiography from the third admission shows posterior leaflet of mitral valve heteroplasia and severe mitral regurgita-
tion. B, Transthoracic echocardiography from the fifth admission shows posterior leaflet mitral valve heteroplasia, severe mitral regurgitation, and increased
echodensity of the left ventricle. C, Transthoracic echocardiography from the fifth admission shows the bioprosthetic valve to be in good condition; however,
the left ventricular (LV) apex is attached with 1 hyperechoic group about 1 cm in diameter (arrow). There is significant activity.
Case Reportsadmission, about 1 month after the first, renal biopsy showed
convalescence of endocapillary proliferative glomerulone-
phritis, but no eosinophilic infiltration was found (Figure 1,
A). Bone marrow aspiration showed granulocyte series active
proliferationwith an elevated eosinophil ratio (Figure 1,B). At
a third admission 2 months after the second discharge, bone
marrow aspiration biopsy showed granulocyte series active
proliferation and revealed the percentage of eosinophils to
be greater than 17% among other cells seen (Figure 1, C
and D). TTE showed posterior leaflet of mitral valve hetero-
plasia and severe mitral regurgitation (Figure 2, A). Oral ther-
apy with prednisolone (60 mg/d for 1 week, gradually
decremented in 2 months) was begun. Cyclosporine (INN ci-
closporin, 150 mg/d) was used in the next 3 months and then
changed back to prednisolone (20 mg/d for 2 months). In the
fourth hospitalization, chest computed tomography showed
the left chest cavity to be full of pleural effusion.
Before the fifth admission, the patient had stopped taking
oral prednisolone for almost 2 months. Blood eosinophilicFIGURE 3. Intraoperative photographs show anterior leaflet prolapse of the
tendineae clinging to the posterior wall of the left ventricle (B).
e46 The Journal of Thoracic and Cardiovascular Surgcount also exceeded normal value (percentage of eosino-
phils to be greater than 12. 6% among white blood cells).
Cardiac function was scored as New York Heart Associa-
tion functional class III to IV. TTE showed posterior leaflet
mitral valve heteroplasia, severe mitral regurgitation, and
increased echodensity of the left ventricle (Figure 2, B).
The patient underwent mitral valve replacement (MVR)
with a bioprosthesis (Hancock II; Medtronic, Inc, Minneap-
olis, Minn). During the operation, we found anterior leaflet
prolapse of the mitral valve (Figure 3, A), with posterior
leaflet and incapable dissociated chordae tendineae clinging
to the posterior wall of the left ventricle (Figure 3, B). In
light of the possibilities of infection and influence on wound
healing, the patient was not given steroids or chemothera-
peutic agents to normalize the peripheral eosinophil count
before leaving hospital. His cardiac function returned to
New York Heart Association functional class I to II, and
had a normal lifestyle after discharge. Mitral valve pathol-
ogy showed proliferation of fibrous tissue.mitral valve (A) and posterior leaflet and incapable dissociated chordae
ery c November 2013
Case ReportsAt his final admission, 2 years after MVR, he returned for
fever and oliguria of nearly 2 weeks’ standing. Routine
blood tests showed the total number of leukocytes to be
2. 3 3 109 cells/L. Neutrophil ratio was 78.3%, and blood
eosinophilic count was normal. The serum creatinine value
was 142 mmol/L. TTE showed the bioprosthetic valve to
be in good condition; however, the left ventricular apex
was attached with a single hyperechoic group about 1 cm
in diameter. It had significant activity (Figure 2, C). This
time, infective endocarditis was diagnosed. Although blood
bacterial culture results were negative, we used cephalospo-
rins and vancomycin to treat empirically. One week after
admission, the patient’s state was getting worse. Serum
creatinine value reached 417 mmol/L. Worse, he suddenly
became comatose. Brain computed tomographic scan
showed cerebral infarction next to the posterior horn of the
left frontal lateral ventricle. The patient appeared to be in
respiratory failure, and we had to use ventilator therapy. Un-
fortunately, he died of multiple organ failure 31 hours later.
DISCUSSION
Cardiac involvement in IHES is characterized by necrosis
from infiltration of eosinophils and thrombus formation and,
in the late stage, by fibrosis and chronic valvular regur-
gitation.3 Surgical intervention for progressive valvular
dysfunction may become necessary. The experience with
valve replacement in patients with IHES is limited by the
rarity of the disease. Damaged valves can be replaced with
mechanical or bioprosthetic valves. Despite anticoagula-
tion, however, mechanical valve replacement may carry a
high incidence of thrombosis, whereas bioprosthetic valves
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The Journal of Thoracic and Cathe limited number of patients reported with mechanical
valve obstructive thrombosis, reoperation was associated
with high mortality. Obstruction of mechanical valves may
occur rapidly and in some cases has been reported to develop
within days to months of surgery.4 Because of these con-
cerns, the use of bioprosthetic valves has been advocated.5
This case is significant because it fulfills all themain criteria
of IHES. In our case, we prescribed therapywith prednisolone
and cyclosporine before surgical intervention. Prednisolone
and cyclosporine did not appear to resolve the cardiac valve
involvement, the eosinophil counts in peripheral blood and
bone marrow, or the symptoms. After MVR with a bio-
prosthesis, the patient had a normal lifestyle. What is inter-
esting is not only the rarity of the case but the rewarding
response in relief of symptoms and a possible cure. Unfortu-
nately, the patient died of infective endocarditis-associated
complications 2 years afterMVR. This may have been associ-
ated with long-term steroid or chemotherapeutic agent use,
causing the patient’s immune function disorders.
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11:447-9.Development of a life-threatening mediastinal hematoma from
a ruptured bronchial artery aneurysmHee Jung Kim, MD,a Ho Sung Son, MD, PhD,a Sung Bum Cho, MD, PhD,b and Kwang Taik Kim, MD,
PhD,a Seoul, South KoreaMediastinal bronchial artery aneurysm (BAA) is a rare
condition.1-4 It is detected in fewer than 1% of all
patients who undergo selective bronchial arteriography.1
The clinical manifestation of BAA depends on size, loca-
tion, and concomitant disease.4 Rupture can result in
serious complications, such as life-threatening hemorrhage.
We report the case of a 79-year-old woman who was
treated with transcatheter embolization and surgical
removal of a mediastinal hematoma resulting from the
life-threatening rupture of a BAA.rdiovascular Surgery c Volume 146, Number 5 e47
